Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: This spontaneous report was received from a physician via a company representative and refers to an unspecified number of patients of unknown age and gender. The patients'' concurrent conditions and medical history were not provided. The reporter read in an article online that, on unspecified dates, an unspecified number of patients were vaccinated with GARDASIL (lot number, expiry date, dose, route and anatomical site of injection were not reported). Concomitant therapies were not provided. The article reported that an unspecified number of patients developed premature ovarian failure an unspecified time after receiving GARDASIL. Additionally, the article mentioned that an unspecified number of patients passed away on unknown dates, on an unspecified time after receiving GARDASIL. It was unspecified if the patients that passed away were the same patients that developed premature ovarian failure. It was unknown if an autopsy was performed. At the time of reporting, the outcome of premature ovarian failure was unknown. The reporter did not provide a causality assessment between the reported events and the GARDASIL. The cause of death was not mentioned. Additional information is not expected, as the reporting physician did not allow further contact for follow-up.
Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166